CTIS2023-510456-23-00进行中（未招募）1 期
CBR-CMR316-3001
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 106
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A Phase 1b study of inhaled RCT1100 in Adults with Primary Ciliary Dyskinesia Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary ClearanceAdults with Primary Ciliary DyskinesiaMedDRA version: 20.0Level: PTClassification code: 10069713Term: Primary ciliary dyskinesia Class: 100000004850CTIS2023-510521-14-00Recode Therapeutics Inc.12
进行中（未招募）
1 期
Assessment of narrowing of blood vessels after single application of two clascoterone formulations (cream and solution) onto the skin in comparison to three marketed topical corticosteroidsTest of vasocontriction properties for classification of topical steroid potencyMedDRA version: 20.0Level: LLTClassification code: 10047140Term: Vasoconstriction peripheral Class: 10047065CTIS2023-507241-28-00Cassiopea S.p.A.33
进行中（未招募）
1 期
A study in healthy men to test how BI 764198 is processed in the bodyMedDRA version: 21.0Level: LLTClassification code: 10053349Term: Pharmacokinetic study Class: 10022891HealthyCTIS2022-502327-22-00Boehringer Ingelheim International GmbH16
招募中
1 期
Individualization of dosage regimens in obese patients: application to acyclovirobesityCTIS2022-500879-31-00Centre Hospitalier Universitaire De Toulouse20
进行中（未招募）
1 期
MK-1403 Single Dose Formulation PK StudyMedDRA version: 20.0Level: LLTClassification code: 10003601Term: Atherosclerosis Class: 10047065AtherosclerosisCTIS2023-507984-20-00Merck Sharp & Dohme LLC16